Flo-Pred

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flo-Pred

Quick Facts

Property Description
Active ingredient Prednisolone Acetate
Form Oral suspension (liquid)
Pharmacological class Glucocorticoid, Corticosteroid
Common use Systemic anti-inflammatory and immunosuppressive
Origin Synthetic

What Type of Medicine is Flo-Pred (Prednisolone Acetate)?

Flo-Pred is a prescription-only medicinal product whose active component is Prednisolone Acetate, chemically categorized as a glucocorticoid within the broad pharmacological class of corticosteroids. This substance is synthetic, having been manufactured to mirror the action of cortisol, a vital steroid hormone naturally produced by the adrenal glands. It is a derivative of the common glucocorticoid prednisolone.

This classification is foundational, as glucocorticoids are clinically recognized for their powerful regulatory effects on inflammatory and immune pathways. The defining function of Prednisolone Acetate is its potent role as an anti-inflammatory and immunosuppressive agent, clarifying its general use in controlling systemic inflammatory processes or immune activity. This preparation is a differentiated product often positioned for use in pediatric populations or others requiring highly manageable liquid forms.

Flo-Pred’s Formulation and General Purpose

Flo-Pred is formulated as an oral suspension, a specific liquid preparation designed for internal intake via the oral route of administration. This formulation is distinguished by its composition: fine, solid particles of Prednisolone Acetate dispersed evenly within an aqueous vehicle, confirming it as a single-ingredient product.

The oral suspension form provides a critical advantage, as it is generally easier to administer to patient groups with difficulty swallowing solid medication like tablets. Prednisolone functions by modulating gene expression to suppress the release of chemical mediators that drive inflammation. The medicine's core purpose is thus to achieve this robust systemic anti-inflammatory effect, thereby controlling symptoms and distress linked to widespread, excessive inflammatory or immune responses.

Regulatory References

  1. NIH: Prednisone/Prednisolone Mechanism of Action
  2. Anti-inflammatory and Immunosuppressive Effects of Glucocorticoids

What side effects are possible with Flo-Pred?

The official safety profile for Flo-Pred (Prednisolone Acetate), a systemic glucocorticoid, details potential adverse reactions that are often linked to the dosage and duration of treatment, affecting multiple organ systems.

Adverse Reaction Scope

Category Description
Common Adverse Reactions Fluid retention, elevated blood pressure, increased appetite and weight gain, and various behavioral or mood changes (e.g., euphoria, insomnia) are frequently observed and documented in regulatory labeling.
System-Organ Classes Involved Adverse effects are categorized by System-Organ Class and include Endocrine Disorders (adrenal suppression), Musculoskeletal Disorders (osteoporosis, muscle weakness), Metabolic Disorders (hyperglycemia), and Ophthalmic Effects (glaucoma, cataracts).
Serious Adverse Reactions Officially documented serious risks include gastrointestinal perforation, acute adrenal insufficiency upon abrupt cessation after prolonged use, and severe psychiatric disturbances, requiring specific attention in the regulatory profile.

Safety Considerations

The label notes that long-term exposure is associated with an increased incidence of effects like osteoporosis and the development of a Cushingoid state. For pediatric patients, potential growth retardation is a stated concern, necessitating monitoring. The medicine is formally contraindicated in patients with known systemic fungal infections or a documented hypersensitivity to the formulation.


Regulatory Safety Summary

The regulatory profile clearly defines risks based on frequency, duration of use, and affected body systems. This structure ensures that potential serious and long-term effects, such as adrenal suppression and changes in bone density, are explicitly communicated as part of the medicine's official safety constraints.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information addresses the clinical manifestations of both acute and chronic overexposure to prednisolone acetate.

Feature Regulatory Documentation Statement
Documented Overdose Presentation Acute overdosage from a single oral dose will not ordinarily cause acute problems [FDA Prescribing Information]. Chronic overexposure may lead to an increased severity of known corticosteroid adverse effects, including the development of Cushingoid features, HPA axis suppression, or peptic ulcer [Regulatory-aligned text].
Physiological Systems Affected Systems primarily affected by chronic overdosage include the endocrine (adrenocortical function), gastrointestinal (ulceration), and cardiovascular systems [Regulatory-aligned text].
Emergency-Response Statement Immediate action for accidental ingestion is to drink fluids to dilute [FDA Prescribing Information]. Individuals must immediately call their local emergency number (e.g., 911) or a Poison Control Center for guidance [MedlinePlus].
Antidote Information No specific antidote is documented for prednisolone overdose [Regulatory-aligned text].

Official Overdose Statements:

  • Overdose management involves supportive and symptomatic therapy. For a recent acute overdose, treatment may include gastric lavage or inducing vomiting [Regulatory-aligned text].
  • Chronic overdosage is managed by a physician through dose reduction or an alternate-day schedule [Regulatory-aligned text].
  • Urgent medical attention is required for assessment, monitoring, and supportive therapy, which includes observation of vital signs and checks for changes in heart rhythm [MedlinePlus].

Connection to the overall overdose profile: The regulatory profile clearly establishes that while a single large dose is not expected to cause immediate life-threatening complications, seeking emergency medical care is mandatory. This is required for professional assessment, monitoring, and to initiate supportive measures. The treatment is constrained to symptomatic management and procedural steps due to the formally documented absence of a specific antidote.

Therapeutic Uses of Flo-Pred

The oral suspension Flo-Pred (Prednisolone Acetate) is utilized across therapeutic domains where additional symptomatic support for heightened inflammation and excessive immune responses is needed. It is primarily applied in contexts where symptoms have become acute, widespread, or significantly disruptive to daily function. The medication is generally indicated for use as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, nervous system, renal, respiratory, and rheumatologic conditions.


Key Therapeutic Contexts and Symptom Relief

Flo-Pred is commonly used during phases when symptoms become more noticeable, particularly for severe allergic conditions and debilitating inflammatory states across the body. It helps address symptom clusters that include acute swelling, redness, and intense itching, offering symptomatic relief that assists patients in coping more steadily with difficult episodes. For instance, in contexts marked by increased discomfort from autoimmune diseases such as Lupus, active Rheumatoid Arthritis, and acute flares of Inflammatory Bowel Disease, it provides supportive relief when symptoms interfere with routine activities. The medication is also applied in clinical settings that involve acute or unstable symptom patterns, such as severe asthma exacerbations.

“It is generally used in conditions where temporary symptomatic support for inflammatory and immune-modulating processes may be considered relevant for symptomatic management.”

Quick Fact: Relief for Systemic Inflammation
The medication supports the patient during difficult episodes by helping to ease discomfort related to symptoms of inflammation and immune overactivity across multiple organ systems.

Eligibility and Restrictions for Use

Flo-Pred (prednisolone acetate ophthalmic suspension) eligibility is strictly defined by regulatory contraindications and restrictions, primarily related to ocular infections and patient status.

Contraindicated Populations

Use is prohibited for individuals with known or suspected hypersensitivity to any component of the suspension. The medicine is also absolutely contraindicated in the presence of most viral diseases of the cornea and conjunctiva, including epithelial Herpes Simplex Keratitis, as well as mycobacterial (tuberculosis) or fungal diseases of the eye.

Age and Physiological Status

Population Group Eligibility Status (Regulatory)
Pediatric Patients Safety and effectiveness are not established; use is generally not recommended.
Older Adults Use is established; no significant differences in safety or effectiveness observed compared to younger adults.
Pregnancy Conditional use; should only be used if the potential benefit justifies the potential risk to the fetus.
Lactation Use is not recommended due to the unknown level of systemic absorption and the potential risk of adverse effects in the nursing infant.

Eligibility-Related Restrictions

Patients with glaucoma, a history of Herpes Simplex Keratitis, or thin corneal or scleral tissue require caution and frequent monitoring (such as Intraocular Pressure checks) if the medicine is used.

What should I know about interactions with other medicines?

Flo-Pred, which contains prednisolone, may interact with several medicinal products and substance categories, primarily requiring cautious co-administration and monitoring.

Documented Interacting Categories

Product Category Interaction Mechanism and Effect Monitoring/Constraint
Anticoagulant Agents May enhance or diminish the blood-thinning effects. Coagulation indices (INR) must be monitored closely.
Antidiabetic Agents May increase blood glucose concentrations. Dose adjustment of antidiabetic medications may be required.
CYP 3A4 Inducers (e.g., Rifampin) Increase corticosteroid clearance/metabolism. May necessitate an increase in Flo-Pred dosage.
CYP 3A4 Inhibitors (e.g., Ketoconazole) Decrease corticosteroid clearance/metabolism. May necessitate a decrease in Flo-Pred dosage.
Cyclosporine Concurrent use increases the activity of both drugs. Convulsions have been reported with this combination.
NSAIDs and Salicylates (e.g., Aspirin) Increased risk of gastrointestinal side effects (e.g., ulceration). Use with caution, especially long-term.
Live or Live Attenuated Vaccines Potential for dissemination due to immunosuppression. Must not be administered during immunosuppressive dosing.

The most significant restriction involves the contraindication of live or live attenuated vaccines while receiving immunosuppressive doses of the corticosteroid. Furthermore, due to the drug’s potential to activate latent diseases, caution is advised for patients with dormant infections like tuberculosis or Strongyloides (threadworm) infestation.

Mechanism of Action

Flo-Pred, containing prednisolone acetate, undergoes ester hydrolysis to release the active molecule, prednisolone. Prednisolone is a lipophilic synthetic glucocorticoid that readily diffuses across the cellular membrane to interact with its primary biological target, the cytosolic glucocorticoid receptor (GCR). This interaction is an agonist type. Binding causes the dissociation of chaperone proteins, permitting the newly formed prednisolone-GCR complex to translocate into the cell nucleus.

Within the nucleus, the complex acts as a transcription factor, modulating gene expression via two main mechanisms: transactivation and transrepression. Through transactivation, the homodimer complex binds to specific glucocorticoid response elements (GREs) on the DNA, upregulating the transcription of genes for anti-inflammatory proteins, such as annexin A1 (lipocortin-1) and interleukin-10 (IL-10). Annexin A1 inhibits phospholipase A2 (PLA2), preventing the release of arachidonic acid and subsequent synthesis of pro-inflammatory eicosanoids like prostaglandins and leukotrienes.

Via transrepression, the complex interferes with the activity of pro-inflammatory transcription factors, including Nuclear Factor-kappa B (NF-κB) and Activator Protein 1 (AP-1), thereby inhibiting the transcription of genes encoding pro-inflammatory cytokines, chemokines, and adhesion molecules. The cellular consequence is a suppressed leukocyte migration and reduced capillary permeability. System-level physiological modulation involves suppression of immune cell function and broad modulation of inflammatory signaling cascades.

Dosage and Administration Information

How Flo-Pred is Used: Administration and Dosing Principles

Flo-Pred (prednisolone acetate oral suspension) is administered exclusively via the oral route, meaning the liquid medication is intended to be swallowed. This form requires specific procedural steps: the bottle must be shaken well immediately before measuring the dose to ensure the active ingredient is uniformly suspended. The measured dose, which must be taken using a calibrated device for accuracy, may be consumed with food or milk to potentially lessen the chance of gastrointestinal irritation.

Official Dosing and Duration Patterns

The established usage protocols define a highly individualized initial dosage for adults, typically ranging from 5 mg to 60 mg per day. This starting dose is variable and depends upon the specific condition being addressed. Dosing is generally prescribed either once daily or in divided doses throughout the day. For certain long-term maintenance scenarios, intermittent regimens, such as dosing every other day, are also an officially recognized use pattern.

Treatment duration can range from short courses for acute issues to long-term maintenance, but a critical procedural constraint is the mandatory dose reduction (tapering) required when discontinuing the medication. After prolonged use, the drug must not be stopped abruptly; a gradual tapering schedule is essential to safely withdraw treatment. For pediatric patients, dosing is highly specific and often calculated based on the child's body weight or surface area.

Recent Clinical Evidence

Research evidence / Overview of studies for Flo-Pred

The research evidence for Flo-Pred (prednisolone acetate oral suspension) draws upon a substantial body of clinical trials and systematic reviews concerning its active component, prednisolone, which was studied for its role in conditions involving systemic inflammatory or immune-related imbalances. The findings describe group patterns and do not determine whether an individual will respond similarly.


Evidence for Use in Acute Inflammatory Episodes

This section will summarize the available evidence, primarily from short-course Randomized Controlled Trials (RCTs) and Systematic Reviews, in research contexts involving conditions characterized by sudden, severe inflammation, which include asthma exacerbations. It will describe the key outcomes monitoring physiological status studied by researchers, including measures of symptom resolution and the use of healthcare services.

The active component was studied extensively during periods of increased symptom activity. Research examined outcomes such as the rates of subsequent episodic changes and the use of healthcare services. Studies explored the observed patterns when comparing outcomes from the use of this medication.

Evidence for Use in Chronic Inflammatory and Autoimmune Conditions

This block will detail the evidence base for long-term and intermediate use of the active component in conditions like Rheumatoid Arthritis (RA). The discussion will focus on trials that examined changes in disease progression using objective tools like radiographic assessments, and studies that tracked measures of functional status and patient-reported pain scores.

The active component was studied for its role in chronic conditions, particularly those marked by functional limitations and fluctuating manifestations, such as active RA. This was evaluated over time intervals lasting one to two years using objective radiographic (X-ray) measures. Studies report how pain measures evolved in the observed populations, indicating that the initial changes were less sustained after the six-month interval.

Research Gaps and Areas of Uncertainty

This final block will synthesize and clarify the current limitations within the evidence base. Certainty remains low for specific comparisons because the research body is heterogeneous. Data for certain groups remain insufficient, and there is limited information for the effects that extend beyond a one-to-two-year timeframe. Research provides insight into short-term changes, but further studies are ongoing to address these gaps.

Frequently Asked Questions (FAQ)

Common questions about Flo-Pred (FAQ)


Q: What should I do if I forget a dose of Flo-Pred?

A: If a dose is forgotten, official guidance indicates it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the individual should skip the missed dose and resume the regular dosing schedule. It is typically advised not to take two doses at the same time to compensate for a missed dose.


Q: Can Flo-Pred be taken with antibiotics?

A: The official product information lists interactions with specific drug categories, including those that affect liver enzyme systems. Since antibiotics are a broad class of medications, there is a potential for interaction that may require caution or dosage adjustments. The disclosure of all current medications to a healthcare professional is considered a standard step for safety.


Q: Does Flo-Pred cause stomach upset?

A: The official safety profile notes that this medication is associated with a risk of gastrointestinal side effects, including the potential for irritation or ulceration. The medication’s administration instructions often state it may be consumed with food or milk, which is a method described to potentially lessen the chance of stomach upset.


Q: Does Flo-Pred affect energy levels?

A: Adverse effects listed in official sources include general discomfort and fatigue. More severe side effects related to the adrenal glands (HPA axis suppression) can also result in unusual weakness or low energy. Changes in energy, particularly if prolonged or severe, are considered important information to discuss with a healthcare professional.


Q: Can someone with diabetes take Flo-Pred?

A: Yes, but official warnings state that corticosteroids can raise blood glucose concentrations and may cause symptoms of latent (hidden) diabetes to appear. Patients with diabetes may require closer monitoring of blood sugar levels and potential dose adjustments for their antidiabetic medicines.


Q: Are there any required tests while taking Flo-Pred for a long time?

A: Yes, for prolonged use, regulatory documents indicate that monitoring is required for potential effects such as HPA axis suppression (the body’s natural hormone production) and elevated blood sugar. Other monitoring may include checks of blood pressure and serum electrolyte levels (e.g., sodium and potassium).


Q: Is Flo-Pred the same thing as prednisone?

A: Flo-Pred contains the active ingredient prednisolone acetate, which the body quickly processes into the active medicine prednisolone. Prednisone is a related, inactive drug that requires a different process in the liver to be converted into prednisolone before it can work. The two agents are distinct but chemically related compounds.


Q: How quickly does Flo-Pred start to work for inflammation?

A: Prednisolone is generally known to work quickly once administered. The effects of the medication on reducing inflammation may be noticed within a few hours to about a day after the first dose is taken. The total time for onset can vary depending on the specific condition being addressed in research.


Q: How is the liquid form of Flo-Pred different from a pill?

A: The liquid form (oral suspension) is specifically formulated with prednisolone acetate for patients who may have difficulty swallowing tablets. Many common pill forms of this drug class contain prednisone, which is structurally different and must first be processed by the liver to become active as prednisolone.


Q: Does Flo-Pred affect blood sugar levels?

A: Yes, official warnings confirm that corticosteroids like this one can cause a condition called hyperglycemia (high blood sugar levels). This potential effect is why blood sugar levels may need to be closely monitored during treatment.


Q: Does alcohol interact with Flo-Pred?

A: While regulatory sources do not typically prohibit the combination, it is noted that both alcohol and the medication can independently increase the potential risk of developing gastrointestinal issues, such as bleeding or ulceration. Both may also potentially worsen certain mood side effects.


Q: Can Flo-Pred make you feel anxious?

A: Yes, official safety information indicates that corticosteroids may cause behavioral and mood disturbances. Documented reactions include, but are not limited to, changes such as anxiety, insomnia, mood swings, and a feeling of euphoria.


Q: Does Flo-Pred interact with common heartburn medications?

A: Official information suggests that some common heartburn relief medications, specifically antacids containing aluminum or magnesium, may potentially reduce how much of the medicine is absorbed. Official guidance often suggests separating the administration of these products by at least two hours to manage this potential effect.


Q: Does Flo-Pred have a risk of dependence?

A: The drug does not typically cause the dependence associated with misuse, but it can cause physical dependency on the body's natural hormone production (HPA axis suppression). For this reason, a gradual reduction (tapering) is necessary after prolonged use to prevent a serious condition called acute adrenal insufficiency.


Q: Is Flo-Pred used for non-inflammatory conditions?

A: Yes, in addition to being used as an anti-inflammatory and immunosuppressive agent, the drug is officially indicated for treating certain endocrine conditions. These conditions include specific types of primary and secondary adrenocortical insufficiency (when the adrenal gland does not produce enough hormones).


Q: Is it normal to feel extra hungry while on Flo-Pred?

A: Yes, official regulatory documents list increased appetite as a common adverse reaction associated with this medication. This increase in hunger is also noted as a factor that can contribute to weight gain during treatment.


Q: Does Flo-Pred have an effect on blood pressure?

A: Yes, the official safety profile notes that this medication can be associated with elevated blood pressure (hypertension). It is also known to potentially cause salt and water retention, and blood pressure monitoring is usually advised.


Q: What is the role of Flo-Pred in managing asthma flare-ups?

A: The drug is officially indicated for use in pulmonary diseases, including the management of asthma. Its primary role is to act as an anti-inflammatory agent, helping to reduce the severe inflammation and suppress the excessive immune response that occurs during a flare-up.


Q: Does Flo-Pred interact with herbal supplements?

A: While no specific herbal supplements are listed on the official label, many supplements can affect the liver enzymes (such as CYP 3A4) that process corticosteroids. This potential effect means that careful consideration of all substances, including herbal supplements, is necessary.

How should Flo-Pred be stored and disposed of?

How to Store and Dispose of Flo-Pred (Prednisolone Acetate Oral Suspension)

Flo-Pred must be stored strictly according to the conditions defined in its official regulatory labeling to maintain stability.

Storage Conditions

Constraint Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Container Keep in the original container and keep the cap tightly closed.
Protection Keep from freezing; freezing is prohibited.
Child Safety Store the medicine out of the reach of children.

Disposal Instructions

Unused or expired Flo-Pred must be disposed of in a manner compliant with local regulations. Patients should consult a healthcare professional or pharmacist for official instructions on how to properly discard any remaining medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flo-Pred found in:

A-Z Index: